hVIVO plc (formerly Open Orphan plc)

Company Profile

Company website
Health Care Providers (Health Care Services)

hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

Investor Access

08 Sep
Event information

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Thursday 8th September 2022 at 18:00 relating to the interim results for the six months ended 30 June 2022.  Investors can sign up to Investor Meet Company for free, by clicking here

Thursday 8th September 2022 at 18:00
Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results* June
Interim Results* September
AGM* July

* Months based on previous announcements of this kind